Danish biotech (Nasdaq: GMAB) on Saturday revealed that US pharma major (AbbVie (NYSE: ABBV) has filed a complaint in the US ...

Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options ...

As previously reported, Erste Group upgraded AbbVie (ABBV) to Buy from Hold. The firm notes AbbVie recently confirmed its ...

AbbVie Inc. enters the obesity market with GUBamy, a promising amylin analog. Click here to find out why ABBV stock is a Buy.

Company Announcement <li /> AbbVie Inc. files complaint against Genmab in the U.S. District Court for the W ...

AbbVie (NYSE:ABBV) is navigating significant shareholder activism as it urges opposition to two governance proposals ahead of ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

AbbVie has not pursued any development of products incorporating their alleged trade secrets. Genmab categorically refutes these allegations and will vigorously defend the company against AbbVie ...

GLP-1 drugs are taking up a bigger share of spending on medical aesthetics, putting pressure on some of the company’s products. Yet, AbbVie stayed on the sidelines as a who’s who of top drug ...

We recently published a list of 13 Best Healthcare Dividend Stocks to Invest in. In this article, we are going to take a look ...